BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 992712)

  • 1. Eosinophils and mediators of anaphylaxis. Histamine and imidazole acetic acid as chemotactic agents for human eosinophil leucocytes.
    Immunology; 1976 Nov; 31(5):797-802. PubMed ID: 992712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotactic activity of guinea pig eosinophils for the ECF-A acidic tetrapeptides, histamine, histamine metabolites, and the effect of H1- and H2-receptor antagonists.
    Jones DG; Kay AB
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):277-82. PubMed ID: 22498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human eosinophils, acidic tetrapeptides (ECF-A) and histamine. Interactions in vitro and in vivo.
    Turnbull LW; Evans DP; Kay AB
    Immunology; 1977 Jan; 32(1):57-63. PubMed ID: 403129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of heparin on leucocyte chemotactic factors.
    Czarnetzki BM; Panneck W; Frosch PJ
    Clin Exp Immunol; 1980 Feb; 39(2):526-31. PubMed ID: 6771079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil chemotactic factor of anaphylaxis (ECF-A): cellular origin, structure and function.
    Geotzl EJ; Austen KF
    Monogr Allergy; 1977; 12():189-97. PubMed ID: 335214
    [No Abstract]   [Full Text] [Related]  

  • 8. Eosinophil leucocytes: recruitment, localization and function in immediate-type hypersensitivity.
    Kay AB
    Monogr Allergy; 1977; 12():222-30. PubMed ID: 411026
    [No Abstract]   [Full Text] [Related]  

  • 9. Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor.
    Capron M; Capron A; Goetzl EJ; Austen KF
    Nature; 1981 Jan; 289(5793):71-3. PubMed ID: 7453810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge.
    Soter NA; Wasserman SI; Austen KF
    N Engl J Med; 1976 Mar; 294(13):687-90. PubMed ID: 55969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity.
    Goetzl EJ; Wasserman SI; Austen F
    Arch Pathol; 1975 Jan; 99(1):1-4. PubMed ID: 234219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a).
    Kay AB; Shin HS; Austen KF
    Immunology; 1973 Jun; 24(6):969-76. PubMed ID: 4123965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of leukotriene B4, leukotriene C4, zymosan activated serum, histamine, tabanid extract and N-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils.
    McEwen BJ; Wilcock BP; Eyre P
    Can J Vet Res; 1990 Oct; 54(4):400-4. PubMed ID: 2174292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptides modulate human eosinophil chemotaxis.
    Numao T; Agrawal DK
    J Immunol; 1992 Nov; 149(10):3309-15. PubMed ID: 1385521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid.
    Morita E; Schröder JM; Christophers E
    J Immunol; 1990 Mar; 144(5):1893-900. PubMed ID: 2155268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes.
    Czarnetzki BM; König W; Lichtenstein LM
    Int Arch Allergy Appl Immunol; 1978; 56(5):398-408. PubMed ID: 344231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527).
    Wasserman SI; Whitmer D; Geotzl EJ; Austen KF
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):301-6. PubMed ID: 1129271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A).
    Wasserman SI; Goetzl EJ; Austen KF
    J Immunol; 1974 Jan; 112(1):351-8. PubMed ID: 4812176
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S),15(S)-dihydroxy-5,9,11,13(Z,E,Z,E)-eicosatetraenoic acid.
    Sehmi R; Cromwell O; Taylor GW; Kay AB
    J Immunol; 1991 Oct; 147(7):2276-83. PubMed ID: 1655889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous eosinophil accumulation in atopic and non-atopic individuals: the effect of an ECF-A tetrapeptide and histamine.
    Bryant DH; Kay AB
    Clin Allergy; 1977 May; 7(3):211-7. PubMed ID: 332409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.